Casdin Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-175,000
| Closed | -$13.1M | – | 43 |
|
|
2020
Q1 | $13.1M | Buy |
+175,000
| New | +$13.1M | 1.39% | 23 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 33 |
|
|
2019
Q2 | – | Sell |
-80,000
| Closed | -$5.2M | – | 33 |
|
|
2019
Q1 | $5.2M | Buy |
+80,000
| New | +$5.2M | 0.57% | 28 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 34 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 35 |
|
|
2018
Q1 | – | Sell |
-30,000
| Closed | -$2.15M | – | 31 |
|
|
2017
Q4 | $2.15M | Buy |
+30,000
| New | +$2.15M | 0.52% | 24 |
|
|
2017
Q3 | – | Sell |
-75,000
| Closed | -$5.31M | – | 28 |
|
|
2017
Q2 | $5.31M | Buy |
+75,000
| New | +$5.31M | 1.96% | 21 |
|
|
2017
Q1 | – | Sell |
-12,500
| Closed | -$895K | – | 30 |
|
|
2016
Q4 | $895K | Buy |
+12,500
| New | +$895K | 0.74% | 25 |
|